Epidemiology of mesothelioma in Egypt. A ten-year (1998-2007) multicentre study

Archives of Medical Science

Volumn 6, Issue 6, 2010, Pages 926-931

  Akl, Yosri ^a   Kaddah, Safy ^a   Abdelhafeez, Ahmed ^a   Salah, Randa ^b   Lotayef, Mohamed ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Asbestos; Epidemiology; Malignant pleural mesothelioma

Indexed keywords

ANTINEOPLASTIC AGENT; ASBESTOS;

ARTICLE; CANCER SURVIVAL; EGYPT; ENVIRONMENTAL EXPOSURE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALIGNANT MESOTHELIOMA; MESOTHELIOMA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OVERALL SURVIVAL; PLEURA BIOPSY; PLEURA MESOTHELIOMA; POLLUTION; SURVIVAL TIME; THORAX RADIOGRAPHY;

EID: 78751517226     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.19303     Document Type: Article

References (25)

1. Granville L, Laga AC, Allen TC, et al. Review and update of uncommon primary pleural tumors. A practical approach to diagnosis. Arch Pathol Lab Med 2005; 129 : 1428-43.
2. Yang H, Testa JR, Carbone M. Mesothelioma epidemiology, carcinogenesis and pathogenesis. Curr Treat Options Oncol 2008; 9: 147-57.
3. Madkour M, Ally Eldin N, Mourad I. Environmental exposure to asbestos and the exposure-response relationship with mesothelioma. East Mediterr Health J 2009; 15: 25-38.
4. Abratt R, Voriobiof D, White N. Asbestos and mesothelioma in South Africa. Lung Cancer 2004; 455: 53-60.
5. Wagner J, Sleggs C, Marchand P. Diffuse pleural mesotheliomas and asbestos exposure in the Northwestern Cape Province. Br J Ind Med 1960; 17 : 260-71.
6. De-Capitani E, Meitze K, Frazato-Junior C, et al. Malignant mesothelioma of the pleura with etiological association to asbestos exposure. Rev Assoc Med Bras 1997; 43: 265-72.
7. Abdel-Rahman NZ, Bahnassy AA, Mohamed WS, et al. Evaluation of simian virus-40 as a biological prognostic Egyptian patients with malignant pleural mesothelioma. Pathol Int 2007; 57: 493-501.
8. Pietruska JR, Kane AB. SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells. Cancer Res 2007; 67: 3637-45.
9. Hillerdal G. Pleural malignancies including mesothelioma. Curr Opin Pulm Med 1995; 1: 339-43.
10. Boutin C, Schlesser M, Frenay C, Astoul Ph. Malignant pleural mesothelioma. ERS Journals Ltd 1998; 12: 972-81.
11. Van Der Most RG, Robinson BW, Nelson DJ. Gene therapy for malignant mesothelioma: Beyond the infant years. Cancer Gem Ther 2006; 13: 897-904.
12. Ceresoli GL, Chiti A, Zucali PA, et al. Early response evaluation in malignant pleural mesothelioma by positron emission tomography with 18F-fluorodeoxyglucose. J Clin Oncol 2006; 24: 4587-93.
13. Gaafar RM, Ally Eldin NH. Epidemic of mesothelioma in Egypt. Lung Cancer 2005; 49 (Suppl. 1): S17-20.
14. Gaafar R, Mokhtar N, Ismail H, et al. molecular markers in malignant pleural mesothelioma. Lung Cancer 2003; 41: S17.
15. Mahgoub K. Environment and occupation as risk factors in a group of mesothelioma patients. Egypt J Occup Med 1999; 23: 55-67.
16. Beer TW, Shepherd P, Pullinger N. Immunostainig is related to prognosis in malignant mesothelioma. Histopathol 2001; 38: 515-41.
17. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin vs. cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003; 21: 2636-44.
18. Whitley NO. Computed tomography and malignant mesothelioma. In: Antman K, Aisner J (eds.). Asbestosrelated Malignancy. Orlando, Grune and Stratton 1987; 265-99.
19. Kawashima A, Libshitz HI. Malignant pleural mesothelioma: CT manifestations in 50 cases. AJR Am J Roentgenol 1990; 155: 965-9.
20. De-Pangher N, Manzini V, Brollo A, et al. Prognostic factors of malignant mesothelioma of the pleura. Cancer 1993, 72: 410-7.
21. Cicenas S, Zaremba S, Jakubauskiene R. Possibilities of diagnosis and treatment of malignant pleural meso-thelioma. Medicina (Kaunas) 2004; 40 (Suppl. 1): 152-5.
22. Barriero TJ, Katzman PJ. Mesothelioma: A case presentation and review. J Am Osteopath Assoc 2006; 106: 699-704.
23. Antman KH, Shemin R, Ryan L, et al. Malignant mesothelioma: Pronostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades 1965- 1985. J Clin Oncol 1988; 6: 147-53.
24. Chahinian APH, Pajak TF, Holland JF, et al. Diffuse malignant mesothelioma (prospective evaluation of 69 patients). Ann Intern Med 1982; 96: 746-55.
25. Montanaro F, Rosato R, Gangemi M, et al. Survival of pleural mesothelioma in Italy: A population-based study. Int J Cancer 2009; 1: 201-7.